Development
Microbot Medical Inc.
MBOT
$2.92
$0.051.74%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -6.95% | 19.84% | 4.84% | 13.55% | 1.28% |
| Total Depreciation and Amortization | -23.08% | 4.00% | -24.24% | 32.00% | 8.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.99% | -11.43% | -8.98% | -8.04% | 6.48% |
| Change in Net Operating Assets | 665.15% | 108.68% | -1,062.03% | 182.14% | 142.42% |
| Cash from Operations | 10.73% | 42.12% | -30.04% | 16.65% | 5.41% |
| Capital Expenditure | -180.00% | -- | -- | 80.00% | 91.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.13% | -144.57% | 176.84% | -- | -- |
| Cash from Investing | -98.61% | -144.92% | 176.82% | -74,960.00% | 91.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -102.40% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -222.91% | 1,215.63% | 83.09% | 36.08% | 7.09% |